Circulating Cell-Free Tumor DNA is poised to drive advancements in cancer diagnosis and treatment
The circulating cell-free tumor DNA (ctDNA) market represents a revolutionary approach in the detection and monitoring of cancer. Circulating tumor DNA fragments are released by …